MYSP-2025-PI-014

王瑞兵


下載導師簡歷CV
Section 1: Personal Particulars

王瑞兵
Wang Ruibing
Professor
+853-88224689
rwang@um.edu.mo
N22-8009 Avenida da Universidade
University of Macau
UMAC-Institute of Chinese Medical Sciences
rwang.sklqrcm.um.edu.mo

Research Project provided for Macao Youth Scholars Program:

超分子生物材料和藥劑學
Supramolecular Biomaterials and Pharmaceutics
0831 生物医学工程
1007 药学
1) PhD degree from a top tier university; 2) Academic background in biomaterials, drug delivery, supramolecular materials and clinical translation.
PhD
2024 Macau Science and Technology Award (3rd Prize, Natural Science Award), Macau 2024 Macau Science and Technology Award (3rd Prize, Technological Invention Award), Macau 2022 Macau Science and Technology Award (2rd Prize, Natural Science Award), Macau 2022 Silver Prize for the Guangdong-Hong Kong-Macao Greater Bay Area High-value Patent Portfolio Layout Competition 2022 The First Prize for 2022 Bank of China Trophy One Million Dollar Macao Regional Entrepreneurship Competition 2021 Faculty-Level Outstanding Academic Staff Award, University of Macau 2020 Macau Science and Technology Award (3rd Prize, Technological Invention Award), Macau 2019 2018-2019 Top 1% Reviewer in Cross-Fields by Publons 2019 2018-2019 Top 1% Reviewer in Chemistry by Publons 2019 Chinese Periodic Table of Young Chemist 2019 UM Teaching Excellence Award (only 1 awardee each year at UM), Macau 2019 China Macrocyclic Arenes and Supramolecular Chemistry Rising Star Award, China 2019 Faculty-Level Best Teacher Award, Macau 2018 Macau Science and Technology Award (3rd Prize, Natural Science Award), Macau 2018 Faculty-Level Academic Award, Macau 2016 CNRS Visiting Professorship, Marseille, France

Section 2: Research Interests and Grants

Supramolecular Biomaterials, Smart Drug Delivery, Cell-mimetics, Cytopharmaceuticals, Cell Therapy
8
16
10
Project Title: Development of novel supramolecular polymeric microspheres and their application in radiochemoembolization therapy of liver cancer
Funding Source: FDCT (FDCT-MoST Joint Program)
Duration: 2023-12-01 to 2026-11-30
Funding Amount: 2,054,000.00